Literature DB >> 29424108

A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis.

Lerpen Duangkaew1, Lawan Larsuprom1, Pojnicha Anukkul1, Chalermpol Lekcharoensuk1, Charles Chen2.   

Abstract

BACKGROUND: Generalized demodicosis in dogs can be challenging to manage, especially in adult-onset cases. HYPOTHESIS/
OBJECTIVES: This study evaluated the efficacy of oral fluralaner at the dose of 25-50 mg/kg for the treatment of canine generalized demodicosis. ANIMALS: Client-owned dogs from Bangkok, Thailand, diagnosed with generalized demodicosis according to published criteria.
METHODS: Deep skin scrapings were performed at three to five affected areas to evaluate numbers of mites. Repeat examinations were performed monthly until parasitological cure; dogs were then followed up for two to 12 months. Parasitological cure was defined as two negative skin scrapings achieved one month apart.
RESULTS: One hundred and fifteen dogs were included in the study, 73 with adult-onset demodicosis and 42 with juvenile-onset demodicosis. Twenty one dogs were lost to follow-up and 27 had one negative skin scraping but did not return. Sixty seven dogs (21 with juvenile-onset and 46 with adult-onset disease) reached parasitological cure, which occurred after two, three and four months in 63%, 85% and 100% (respectively) of dogs with adult-onset demodicosis, cumulatively, and after two and three months in 81% and 100% of dogs with juvenile-onset demodicosis. Underlying causes associated with adult-onset demodicosis included atopic dermatitis, neoplasia, metabolic diseases and idiopathy. No adverse effects of fluralaner were observed in any of the dogs.
CONCLUSION: Fluralaner given at the label dose for flea and tick prevention is effective for the treatment of canine generalized demodicosis.
© 2018 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29424108     DOI: 10.1111/vde.12524

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  3 in total

1.  Oral fluralaner as a treatment for Demodex aurati and Demodex criceti in a golden (Syrian) hamster (Mesocricetus auratus).

Authors:  Gabrielle Brosseau
Journal:  Can Vet J       Date:  2020-02       Impact factor: 1.008

2.  A European field assessment of the efficacy of fluralaner (Bravecto®) chewable and spot-on formulations for treatment of dogs with generalized demodicosis.

Authors:  Ivo Petersen; Rafael Chiummo; Eva Zschiesche; Joanna Karas-Tecza; Dhimiter Rapti; Rainer Roepke; Emmanuel Thomas
Journal:  Parasit Vectors       Date:  2020-06-11       Impact factor: 3.876

3.  Efficacy of two formulations of afoxolaner (NexGard® and NexGard Spectra®) for the treatment of generalised demodicosis in dogs, in veterinary dermatology referral centers in Europe.

Authors:  Wilfried Lebon; Massimo Beccati; Patrick Bourdeau; Thomas Brement; Vincent Bruet; Agnieszka Cekiera; Odile Crosaz; Céline Darmon; Jacques Guillot; Marion Mosca; Didier Pin; Jaroslaw Popiel; Dorota Pomorska Handwerker; Diane Larsen; Eric Tielemans; Frédéric Beugnet; Lénaïg Halos
Journal:  Parasit Vectors       Date:  2018-09-10       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.